-morbidities together with the increasing spread of resistant pathogens, prevention is gaining increasing importance. Peri-operative antibiotic prophylaxis during implant surgery is a recognized necessity. Further addition of local antibiotics eluting from bone cement
Christof Berberich and Pablo Sanz-Ruiz
James R Satalich, Daniel J Lombardo, Simon Newman, Gregory J Golladay, and Nirav K Patel
history, properties, techniques, and outcomes of bone cement utilization in THA. History of bone cement Themistocles Gluck is credited as being among the first to experiment with the use of cement for the fixation of artificial joints in the 1880s
Amer Sebaaly, Maroun Rizkallah, Falah Bachour, Firas Atallah, Pierre Emmanuel Moreau, and Ghassan Maalouf
hyperintensity signal on T2 scans, a marker of oedema that is correlated with pain levels and to non-surgical management success ( Fig. 1 ). 8 Percutaneous treatment of these types of fractures consists of bone cement augmentation with or without the use of
Claus Varnum, Alma Bečić Pedersen, Ola Rolfson, Cecilia Rogmark, Ove Furnes, Geir Hallan, Keijo Mäkelä, Richard de Steiger, Martyn Porter, and Søren Overgaard
polyethylene liner. 25 , 26 Several bone cements were also identified as poorly performing after only three years of follow-up, especially the Boneloc cement and a low viscosity cement. 27 , 28 With a longer follow-up, three cemented implants
George C. Babis and Vasileios S. Nikolaou
Pelvic discontinuity (PD) has been a considerable challenge for the hip revision arthroplasty surgeon. However, not all PDs are the same. Some occur during primary cup insertion, resembling a fresh periprosthetic fracture that separates the superior and inferior portions of the pelvis, while others are chronic as a result of gradual acetabular bone loss due to osteolysis and/or acetabular implant loosening.
In the past, ORIF, various types of cages, bone grafts and bone cement were utilized with little success. Today, the biomechanics and biology of PD as well as new diagnostic tools and especially a variety of new implants and techniques are available to hip revision surgeons. Ultraporous cups and augments, cup-cage constructs and custom triflange components have revolutionized the treatment of PD when used in various combinations with ORIF and bone grafts. For chronic PD the cup-cage construct is the most popular method of reconstruction with good medium-term results.
Dislocation continues to be the leading cause of failure in all situations, followed by infection. Ultimately, surgeons today have a big enough armamentarium to select the best treatment approach. Case individualization, personal experience and improvisation are the best assets to drive treatment decisions and strategies.
Cite this article: EFORT Open Rev 2021;6:459-471. DOI: 10.1302/2058-5241.6.210022
Geke A. W. Denissen, Liza N. van Steenbergen, Wouter T. Lollinga, Nico J. J. Verdonschot, Berend W. Schreurs, and Rob G. H. H. Nelissen
components) ( Table 1 ). For bone cement, the name of bone cement, the manufacturer, type of cement, viscosity, whether the cement contains any antibiotics and use of a vacuum cement mixing system are collected ( Table 2 ). In 2014, the process described
Ahmed Fikry Elmenshawy and Khaled Hamed Salem
include a wide variety of internal fixation methods, hemiarthroplasty or total hip replacement. The case for arthroplasty was strengthened by the use of bone cement that allows early mobilization of the fractured, elderly and morbid patients. The aims of
Adrian J. Cassar-Gheiti, Rosie McColgan, Martin Kelly, Theresa M. Cassar-Gheiti, Paddy Kenny, and Colin G. Murphy
Introduction In the 1950s, self-curing polymethylmethacrylate (PMMA), also known as bone cement, was introduced in orthopaedics practice for femoral stem fixation by Edward Haboush (New York), Frederick Roeck Thompson (New York), Kenneth McKee
Anoop K. Prasad, Jaimee H.S. Tan, Hany S. Bedair, Sebastian Dawson-Bowling, and Sammy A. Hanna
devastating complications of joint replacement surgery, and the potential of using antibiotic-infused bone cement (AIBC) in primary cemented fixation may be an argument for its clinical superiority. Our review has demonstrated no significant difference in
T. Fintan Moriarty, Richard Kuehl, Tom Coenye, Willem-Jan Metsemakers, Mario Morgenstern, Edward M. Schwarz, Martijn Riool, Sebastian A.J. Zaat, Nina Khana, Stephen L. Kates, and R. Geoff Richards
the 1970s, when gentamicin-loaded bone cement was first tested in humans. 57 Bone cement was a convenient vehicle for antibiotic delivery, as it was routinely applied in cemented arthroplasties. Gentamicin was identified as a suitable antibiotic